SynthesisInternational journal of radiation oncology, biology, physics2025
Timing of Planning Magnetic Resonance Imaging and Patient Selection for Adaptive Radiation Therapy in Newly Diagnosed High-Grade Glioma.
Synthesis in International journal of radiation oncology, biology, physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeRadiation therapy (RT) planning for high-grade glioma (HGG) typically relies on a single postoperative magnetic resonance image (MRI), assuming stable tumor and brain architecture throughout treatment. Though the gross tumor volume and surrounding tissues can shift after surgery and throughout RT, its rate of change, predictors of the movement magnitude, and impact on different dosing strategies are not well understood. This study uses meta-analysis and prospective MRI data to optimize MRI timing and identify patients who may benefit from adaptive RT (ART). METHODS AND MATERIALS: We performed a meta-analysis of 12 studies (405 patients) to quantify postresection brain morphology changes. Additionally, we prospectively collected MRIs from 17 newly diagnosed HGG patients who underwent resection and RT. Nonlinear image registration tracked voxel-wise movement from postsurgery through RT and follow-up. We analyzed changes in gross tumor volume, clinical target volume (CTV), and non-CTV influx volume (nCIV) across 8 CTV strategies. Exponential models predicted the magnitude and rate of postresection changes and optimal MRI timing.
resultsBoth meta-analysis and prospective data showed that morphological changes followed an exponential decay, with 80% of shifts occurring within ∼30 days of resection. The nCIV was strongly predicted by T2-weighted fluid-attenuated inversion recovery volume and CTV margin strategy (86% accuracy for T1-based and 80% for T2-weighted fluid-attenuated inversion recovery-based CTVs). To minimize nCIV in patients starting RT >3 weeks postsurgery, our model suggests acquiring an additional MRI before RT. Otherwise, RT planning should be adaptive.
conclusionsAcquiring a delayed planning MRI or performing ART based on recent MRIs may optimize RT delivery for patients with larger tumors and specific CTV strategies. We propose a simple, clinically feasible algorithm for selecting patients and determining optimal MRI timing in prospective clinical trials of HGG ART.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.